Nicoretteskin (Nicotine)

Nicotine, the active ingredient in Nicoretteskin, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adult smokers who wish to quit by delivering a steady dose of nicotine to alleviate withdrawal symptoms and reduce cravings. The patch is designed for once‑daily application and provides a controlled release of nicotine over 16–24 hours, supporting a gradual reduction in nicotine dependence.

GNH USA supplies Nicoretteskin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with capabilities for regulatory support, quality assurance and reliable logistics.

Nicoretteskin, a nicotine replacement therapy, is used in the management of nicotine dependence. - Smoking cessation: helps adult smokers reduce cravings and withdrawal symptoms while quitting. - Tobacco dependence: provides a steady nicotine supply to support gradual reduction of use. - Relapse prevention: assists individuals who have quit smoking to maintain abstinence and avoid relapse.

Common and serious adverse reactions may occur with Nicoretteskin use.

Common Side Effects: - Skin irritation: redness, itching, or mild rash at the application site. - Burning sensation: localized warmth or tingling where the patch is placed. - Headache: mild to moderate headache during the initial days of therapy. - Nausea: occasional feeling of queasiness or upset stomach.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or severe rash indicating hypersensitivity. - Severe skin dermatitis: extensive blistering or ulceration at the patch site. - Dizziness or fainting: sudden light‑headedness that may lead to falls. - Chest pain: unexplained thoracic discomfort requiring immediate medical evaluation.

Before using Nicoretteskin, consider the following precautions to ensure safe and effective therapy. - Cardiovascular assessment: evaluate history of heart disease, as nicotine may increase heart rate and blood pressure. - Recent myocardial infarction: avoid use within the first few weeks after a heart attack. - Non‑smokers: do not use the patch if you are not a regular tobacco user. - Concomitant nicotine products: do not combine with other nicotine replacement therapies to prevent overdose. - Pediatric safety: keep patches out of reach of children and pets to avoid accidental exposure. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nicoretteskin may interact with other medicines; awareness of these interactions helps minimize risk.

Major Interactions (Avoid): - Other nicotine products: using nicotine gum, lozenges, or e‑cigarettes can cause nicotine excess. - Monoamine oxidase inhibitors (MAOIs): concurrent use may increase cardiovascular effects of nicotine.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., methoxsalen): may reduce nicotine metabolism, raising plasma levels. - Beta‑blockers: nicotine‑induced tachycardia may be masked, requiring monitoring. - Certain antidepressants (e.g., bupropion): may enhance stimulant effects and affect sleep.